J. Mapoles et al., MAMMALIAN PC-12 CELL GENETICALLY-ENGINEERED FOR HUMAN CYTOCHROME-P4502E1 EXPRESSION, European journal of biochemistry, 214(3), 1993, pp. 735-745
The stable expression of the human cytochrome CYP2E1 (P450 alcohol) wa
s performed in the mammalian cell line PC-12. This cell line expressed
cytochrome b5 (58 +/- 12 pmol/mg microsomal protein vs 528 +/- 80 pmo
l/mg in microsomal human liver) and a high level of NADPH: cytochrome
P450 reductase (140 +/- 20 nmol - min-1 . mg microsomal protein- 1 vs
68 +/- 48 nmol . min-1 . mg-1 in microsomal human liver). An expressio
n plasmid was constructed using the cDNA for the human CYP2E1 mRNA and
the Rous sarcoma virus (RSV) promoter. This plasmid was co-transfecte
d with the plasmid RSVneo into PC-12 cells. Clones were selected for r
esistance to the neomycin analog, G418, and then screened for expressi
on of the CYP2E1 isozyme by testing for 6-hydroxylation of chlorzoxazo
ne, a specific substrate for CYP2E1. Expression of CYP2E1 was confirme
d in one clone, DB-7, by Western blot analysis and by measurement of m
onooxygenase activities which were not detectable in PC-12 cells. Chlo
rzoxazone 6-hydroxylation, n-butanol oxidation and dimethylnitrosamine
N-demethylation were localized in microsomes (62, 60 and 63 pmol . mi
n-1 - mg microsomal protein-1, respectively) and were inhibited by car
bon monoxide and diethyldithiocarbamate, both inhibitors of P450 enzym
es. Although the level of the enzyme activities was about a tenth of t
hat measured in human liver microsomes, CYP2E1 expressed in DB-7 cells
has catalytic competence similar to human liver CYP2E1. DB-7 cells me
tabolized acetaminophen and this metabolic activation was shown to be
toxic to these cells by release of lactate dehydrogenase. Construction
of recombinant cell lines expressing CYP2E1 provides a useful tool fo
r studying the catalytic properties of this enzyme and the consequent
cytotoxic effects of substrates metabolized by this enzyme.